This Is The Structure (Megestrol Acetate Oral Suspension 1)
Megestrol Acetate Suspension
Product Images NDC 0121-0945
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 0121-0945). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Trial 1 (Megestrol Acetate Oral Suspension 2)
The text is readable, and it says "TRIAL 1 Placebo". Based on this, it can be inferred that this is a record or documentation related to a clinical trial, where the first trial used a placebo (inactive substance used as a control). However, no further information is available.*
Trial 2 (Megestrol Acetate Oral Suspension 3)
This text is providing limited information to generate a useful description. It seems to refer to a clinical trial with a placebo intervention, but there is no context or further detail to elaborate on. Therefore, the description cannot be provided.*
Image Description (Megestrol Acetate Oral Suspension 4)
This is a 10 mL bottle of Megestrol Acetate Oral Suspension. Each 10 mL of the suspension contains 400 mg of the medication. It is recommended to shake well before administering the dose. It also states that the package is not child-resistant and should be stored out of reach of children. More information can be found in the insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
